Polaris Group (TPE:6550) FFO


TPE:6550 Polaris Group TPE:6550
59 GF Score
Price NT$12.50
GF Value NT$55.10
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Polaris Group FFO?

FFO (Funds from operations) only applies to REITs.

TPE:6550
59GF Score
Polaris Group TPE:6550
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Polaris Group (TPE:6550) Overvalued in 2026?

Based on GuruFocus' analysis, Polaris Group stock appears to be undervalued. The current stock price of NT$12.50 is trading 77.3% below its estimated GF Value™ of NT$55.10. GuruFocus considers Polaris Group to be Possible Value Trap.

Key valuation signals for TPE:6550:

  • FFO:
  • GF Value™: NT$55.10 vs. price of NT$12.50 (77.3% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the TPE:6550 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polaris Group Business Description

Address Ugland House, PO Box 309, Grand Cayman, CYM, KY1-1104
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.
59GF Score

Get the complete analysis for TPE:6550

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.50
Price
NT$55.10
GF Value